Microbiome and Colorectal Cancer Management

Area of Science:

• Microbiome research
• Cancer biology
• Gastroenterology

Background:

• Colorectal cancer (CRC) is a leading cause of cancer death globally.
• Early detection significantly improves CRC patient outcomes.
• The gut microbiome plays a crucial role in human metabolism and homeostasis.

Purpose of the Study:

• To explore the role of gut microbiome alterations in CRC pathogenesis.
• To investigate the potential of microbiome-based biomarkers for early CRC detection.
• To discuss microbiome-targeted strategies for CRC prevention and treatment.

Main Methods:

• Review of current literature on gut microbiome and CRC.
• Analysis of microbial dysbiosis in CRC carcinogenesis.
• Exploration of biomarker development using microbial signatures.

Main Results:

• Microbial dysbiosis, characterized by an imbalance in gut flora, is linked to chronic inflammation and genetic alterations promoting CRC.
• Specific microbial changes offer potential for developing diagnostic biomarker models for early CRC detection.
• Modulating the gut microbiome presents a promising avenue for CRC prevention and targeted therapies.

Conclusions:

• Gut microbiome analysis is crucial for understanding CRC development.
• Microbiome-based biomarkers could revolutionize early CRC detection.
• Targeted microbiome interventions offer novel therapeutic strategies for personalized CRC management.